Gut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancer
Authors:
Top Cited Papers
Open Access
- 8 June 2020
- journal article
- review article
- Published by Springer Nature in Oncogene
- Vol. 39 (26) , 4925-4943
Abstract
Research about the role of gut microbiome in colorectal cancer (CRC) is a newly emerging field of study. Gut microbiota modulation, with the aim to reverse established microbial dysbiosis, is a novel strategy for prevention and treatment of CRC. Different strategies including probiotics, prebiotics, postbiotics, antibiotics, and fecal microbiota transplantation (FMT) have been employed. Although these strategies show promising results, mechanistically by correcting microbiota composition, modulating innate immune system, enhancing gut barrier function, preventing pathogen colonization and exerting selective cytotoxicity against tumor cells, it should be noted that they are accompanied by risks and controversies that can potentially introduce clinical complications. During bench-to-bedside translation, evaluation of risk-and-benefit ratio, as well as patient selection, should be carefully performed. In view of the individualized host response to gut microbiome intervention, developing personalized microbiome therapy may be the key to successful clinical treatment.Keywords
This publication has 145 references indexed in Scilit:
- Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese womenGut, 2012
- Abating colon cancer polyposis by Lactobacillus acidophilus deficient in lipoteichoic acidProceedings of the National Academy of Sciences, 2012
- Regulated Virulence Controls the Ability of a Pathogen to Compete with the Gut MicrobiotaScience, 2012
- 16. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010British Journal of Cancer, 2011
- Gut barrier dysfunction in the ApcMin/+ mouse model of colon cancer cachexiaBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
- Regulation of induced colonic inflammation byLactobacillus acidophilusdeficient in lipoteichoic acidProceedings of the National Academy of Sciences, 2011
- The dual role of bacteriocins as anti- and probioticsApplied Microbiology and Biotechnology, 2008
- Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised studyBritish Journal of Cancer, 2007
- Prebiotic Galactooligosaccharides Reduce Adherence of EnteropathogenicEscherichia colito Tissue Culture CellsInfection and Immunity, 2006
- Metagenomic Analysis of the Human Distal Gut MicrobiomeScience, 2006